Cigna Forecast, price target & analysts
Cigna Target price 2025 - Analyst rating & recommendation
Cigna Classifications & Recommendation:
Cigna Price Target
| Target Price | $362.05 |
| Price | $311.05 |
| Potential |
16.39%
register free of charge
|
| Number of Estimates | 22 |
|
22 Analysts have issued a price target Cigna 2026 .
The average Cigna target price is $362.05.
This is
16.39%
register free of charge
$405.00
30.20%
register free of charge
$323.00
3.84%
register free of charge
|
|
| A rating was issued by 26 analysts: 19 Analysts recommend Cigna to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Cigna stock has an average upside potential 2026 of
16.39%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 244.38 | 252.36 |
| 25.21% | 3.27% | |
| Net Margin | 1.36% | 2.67% |
| 44.34% | 96.64% |
18 Analysts have issued a sales forecast Cigna 2025 . The average Cigna sales estimate is
This results in the following potential growth metrics:
12 Cigna Analysts have issued a net profit forecast 2025. The average Cigna net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 12.12 | 24.61 |
| 30.30% | 103.05% | |
| P/E | 12.64 | |
| EV/Sales | 0.43 |
12 Analysts have issued a Cigna forecast for earnings per share. The average Cigna <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Cigna stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current Cigna Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | Feb 04 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 04 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Jan 31 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jan 31 2025 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Jan 31 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
Feb 04 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 04 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Feb 03 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 03 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Jan 31 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jan 31 2025 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Jan 31 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
